argenx SE (STU:1AE)
€ 553.6 6 (1.1%) Market Cap: 33.43 Bil Enterprise Value: 30.56 Bil PE Ratio: 0 PB Ratio: 8.44 GF Score: 82/100

Q4 2021 argenx SE Earnings Call Transcript

Mar 03, 2022 / 01:30PM GMT
Release Date Price: €254.6 (-3.19%)
Operator

Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the argenx Fourth Quarter and Full Year 2021 Conference Call. (Operator Instructions) Beth DelGiacco, Vice President, Investor Relations and Corporate Communications, you may begin your conference.

Beth DelGiacco
argenx SE - VP of IR

Thank you, operator. A press release was issued earlier today with our full year 2021 financial results and the recent business update. This can be found on our website along with the presentation for today's webcast.

Before we begin, I'd like to remind you on Slide 2 that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical developments, regulatory time lines, the potential success of our product candidates, financial projections and upcoming milestones. Actual results may differ materially from those indicated by these statements. argenx is not under any obligation to update statements regarding the future or to conform

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot